Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 22, 1997

View Archived Issues

Chlorhexidine solution prevents perinatal infections

ISO 9001 given to Senetek for drug delivery system

EchoGen enters phase III trials

FDA approves hand implant for quadriplegics

Medco and Discovery Therapeutics announce R&D alliance

Gene interaction studies without blood tests

Receptor Technologies announces name change

FDA clears ChromaFlo option for Oracle Invision ultrasound

Meretek UBT breath test for H. pylori now offered by first test center

HIV-O licensed to Abbott

Lasette laser finger perforator receives FDA clearance

Cerebrus develops novel animal satiety model

Murex launches E. coli O157 assay

Second gene discovered that delays AIDS

Interneuron: Q3 1997 highlights

Telomerase-inhibitory oligonucleotides for treating cancer

Apoptosis modulators reported in patent literature

Alexion reports novel retroviral vectors for gene therapy

Melatonin implant delays puberty in rats

Link established between estradiol and melatonin production in adult rats

Supplemental NDA approved for Cipro

Alpha-adrenoceptors may be implicated in obesity

New COX-2 inhibitor series reported by Searle

Living human tissue approved for marketing in Canada

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...